Trial Profile
A study of naive chronic hepatitis B patients either treated or untreated with tenofovir to evaluate the prevalence and incidence of hypophosphatemia and hyperphosphaturia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Dec 2015
Price :
$35
*
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 23 Dec 2015 New trial record